SCHEMBL26075378

SCHEMBL26075378

Cc1ccc2nc(-c3ccc(-c4ccc(OCC(C)C)cc4)c(F)c3)cc(C=O)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ DHODH Q02127 5/20 0.37
▸ MAPT P10636 7/20 0.36
▸ TARBP2 Q15633 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ HPGD P15428 3/20 0.36
▸ THRB P10828 3/20 0.36
▸ LMNA P02545 4/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ HSP90AA1 P07900 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ ACACA Q13085 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075374 0.91 TP53 (0.36) DHODHMAPTALDH1A1HPGDTHRB
SCHEMBL26075369 0.87 KDM4E (0.40) ALOX5APFEN1DHODHMAPTALDH1A1
SCHEMBL26075337 0.86 MAPT (0.49) DHODHMAPTALDH1A1HPGDLMNA
SCHEMBL26075357 0.86 PLA2G2A (0.42) XDHDHODHMAPTALDH1A1HPGD
SCHEMBL26075912 0.86 DHODH (0.52) DHODHMAPTALDH1A1HPGDLMNA
SCHEMBL26075354 0.85 PLA2G2A (0.41) DHODHMAPTALDH1A1HPGDTHRB
SCHEMBL26075362 0.85 PLA2G2A (0.41) DHODHMAPTALDH1A1HPGDTHRB
SCHEMBL26075365 0.85 PLA2G2A (0.41) DHODHMAPTALDH1A1HPGDTHRB
SCHEMBL26075360 0.85 PLA2G2A (0.41) DHODHMAPTALDH1A1HPGDTHRB
SCHEMBL26075408 0.84 DHODH (0.45) DHODHMAPTALDH1A1HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD XDH 34/4885ALOX5AP 821/4885FEN1 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback